Anna-Kristina Kluever

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

Ludwig-Maximilians-Universität München(Current)

Anna-Kristina Kluever is an author at Ludwig-Maximilians-Universität München specializing in chimeric antigen receptor t-cell therapy, antibody therapeutic efficacy, and tumor antigen heterogeneity.

ORCID

Publications per year

2022–2022

Publications

Chimeric antigen receptor T cells engineered to recognize the P329G-mutated Fc part of effector-silenced tumor antigen-targeting human IgG1 antibodies enable modular targeting of solid tumors

Sophia Stock, Mohamed-Reda Benmebarek, Anna-Kristina Kluever et al. · Journal for ImmunoTherapy of Cancer · 2022 · 28 citations · Full text

Life Sciences, Immunology, Oncology +17

1–1 of 1